Diligence memo · auto-generated · as of July 1, 2026
Macromoltek
Macromoltek: limited disclosed financing to assess.
Diligence furtherNo decisive signal either way from the public record alone — the call needs primary diligence beyond the filings.
Businessfiled
Macromoltek is a private company, based in Austin, TX, USA. Computational antibody design
Sub-sector tags: AI-powered Drug Discovery, Deep Learning, Therapeutics.
Capital & rounds (filed)filed
Macromoltek has raised — in disclosed capital across 0 recorded rounds, aggregated from public filings.
Valuation (modeled)modeled
No modeled valuation — too little disclosed financing to estimate one.
Financing rhythm & timingmixed
Not enough dated financing history to read a financing rhythm.
Comparablesmixed
Capital scale ranks ahead of 96% of sector peers (8525 compared).
Modeled value ranks above 96% of those peers.
Risks & flagsmixed
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.